Oscar Health, Inc. (OSCR)
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts
Oscar Health, Inc. (OSCR) closed at $13.23 in the latest trading session, marking a +1.77% move from the prior day.
Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages
Oscar Health, Inc. (NYSE: OSCR - Get Free Report) has been given a consensus recommendation of "Hold" by the ten analysts that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have assigned a buy recommendation to the company. The
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13, representing a -2.99% change from its previous close.
Oscar Health's CEO Says 2026 Is the Year It Finally Turns a Profit — Here's What He's Betting On
Oscar Health ( NYSE:OSCR ) CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns profitable.
Oscar Health, Inc. (OSCR) Crossed Above the 50-Day Moving Average: What That Means for Investors
Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR broke out above the 50-day moving average, suggesting a short-term bullish trend.
Here is What to Know Beyond Why Oscar Health, Inc. (OSCR) is a Trending Stock
Zacks.com users have recently been watching Oscar Health (OSCR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back?
Oscar Health (OSCR) stock has declined by 21.7% in under a month, from $15.70 on January 26, 2026, to $12.30 currently. Should you consider purchasing this dip?
Oscar Health: Macro Headwinds Hurt In 2025 Are Expected; Eyes On Massive Price Discovery In 2026
Oscar Health (OSCR) leverages technology to drive operational efficiency and profitability in a challenging health insurance environment. Despite industry headwinds, OSCR's individual member retention remains strong, supporting optimism for revenue growth and market share gains. 2026 guidance targets $18.7–$19.0B revenue, 82.4–83.4% MLR, 15.8–16.3% SG&A, and $250–$450M operating earnings, implying significant valuation upside.
Oscar Health (OSCR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Misses Revenue Estimates
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to a loss of $0.62 per share a year ago.
Oscar Health Revenue Rises, Eyes Profitability This Year
Oscar Health's fourth-quarter loss widened as the health insurer continued to struggle with the high utilization of medical services by plan enrollees.
Oscar Health Reports $352 Million Loss As Insurers Battle High Costs
Health insurer`Oscar Health Tuesday reported a $352 million fourth quarter loss as the health insurer and its industry battle with an ongoing period of rising healthcare costs.
